<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Ixazomib_Untruths_You%27ve_Been_Informed_Around</id>
		<title>Ixazomib Untruths You've Been Informed Around - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Ixazomib_Untruths_You%27ve_Been_Informed_Around"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Ixazomib_Untruths_You%27ve_Been_Informed_Around&amp;action=history"/>
		<updated>2026-05-03T14:08:45Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Ixazomib_Untruths_You%27ve_Been_Informed_Around&amp;diff=203141&amp;oldid=prev</id>
		<title>Mittenedge34: Створена сторінка: Immediate dilation of this stenotic segment was performed. Two patients with distal embolization were successfully treated by endovascular aspiration in the bel...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Ixazomib_Untruths_You%27ve_Been_Informed_Around&amp;diff=203141&amp;oldid=prev"/>
				<updated>2017-07-15T23:42:30Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Immediate dilation of this stenotic segment was performed. Two patients with distal embolization were successfully treated by endovascular aspiration in the bel...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Immediate dilation of this stenotic segment was performed. Two patients with distal embolization were successfully treated by endovascular aspiration in the below-knee arteries. The 30-day mortality rate was 1%, with one patient who died on the day after the procedure of septic shock induced by methicillinresistant Staphyloncus aureus. Other 30-day complications occurred in four other patients. Blood loss in one patient after the procedure resulted in hemorrhagic shock and an in-stent reocclusion causing ischemia of the left leg. Endovascular thrombectomy was successfully performed to restore the blood flow. Another patient had acute ischemia 5 days after the index procedure, which was successfully treated with thrombolysis. An in-stent thrombosis occurred in one patient on day 12 after the index procedure. Revascularization was achieved by placement of a femoropopliteal below the knee prosthetic bypass. [http://www.selleckchem.com/products/MLN-2238.html Ixazomib supplier] One patient complained of recidivating claudication on day 14 due to an in-stent restenosis in the study stent, which was successfully treated with thrombolysis, followed by percutaneous transluminal angioplasty with stent placement. Compared with baseline, a significant improvement in ABI was found at the 1-month (0.97 �� 0.09, P [http://en.wikipedia.org/wiki/Thalidomide Thalidomide] decreased from 3.04 �� 1.07 at baseline to 0.68 �� 1.13 at 1 year (P [http://www.selleckchem.com/products/Abiraterone.html www.selleckchem.com/products/Abiraterone.html] not a statistically significant difference (P = .67). No statistically significant difference (P = .50) in 1-year primary patency rates was found in stratification between TASC C (68.5%) and TASC D lesions (63.9%). Stratifications on the number of stents used did not show any statistical difference in 12-month primary patency rates, whether one or multiple stents were implanted ( Fig 4). The patient survival rate for the entire population after 12 months was 85.0% ( Fig 5). Stent fractures occurred in six patients (6.&lt;/div&gt;</summary>
		<author><name>Mittenedge34</name></author>	</entry>

	</feed>